Vimarsana
Biggest News Aggregation in the World

Page 35 - Updated March News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Updated March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Updated March Today - Breaking & Trending Today

Surveillance of the Initiation of, Participation in, and Completion of Cardiac Rehabilitation in Minnesota, 2017–2018 - Vimarsana News

Surveillance of the Initiation of, Participation in, and Completion of Cardiac Rehabilitation in Minnesota, 2017–2018

Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.

Source: cdc.gov
Identify, Address Insomnia Causes to Prevent Health Complications - Vimarsana News

Identify, Address Insomnia Causes to Prevent Health Complications

For chronic cases, encourage patients to seek medical care from their primary health care providers.

New SAMHSA CCBHC Criteria Will Foster Innovation in Crisis Services Continuum - Vimarsana News

New SAMHSA CCBHC Criteria Will Foster Innovation in Crisis Services Continuum

The new criteria have been updated to increase flexibility and provide greater clarity around standards for behavioral health clinicians.

NWS updates tornado count for March 31, 2023 - Vimarsana News

NWS updates tornado count for March 31, 2023

An EF0 tornado confirmed in Porter County brings the total for March 31 to 23, the fifth-highest number of tornadoes for a single day in Indiana history.

Source: wthr.com
FDA Fast Tracks BCMA-Targeted CAR T-Cell Therapy for R/R Multiple Myeloma - Vimarsana News

FDA Fast Tracks BCMA-Targeted CAR T-Cell Therapy for R/R Multiple Myeloma

The FDA has granted a fast track designation to CB-011, a CRISPR-edited allogeneic CAR T-cell therapy developed by Caribou Biosciences, for the treatment of patients with relapsed/refractory multiple myeloma.

Source: ajmc.com